Chapter 18: Glycogen Metabolism & Storage

Functioning as a critical energy buffer, liver glycogen maintains systemic blood glucose levels during periods of fasting, while muscle glycogen serves as a localized fuel source to power muscular contraction through glycolysis. The text details the structured biosynthesis of this branched polymer, known as glycogenesis, which begins with the activation of glucose into uridine diphosphate glucose (UDPGlc) and utilizes the specialized protein glycogenin to initiate the formation of a primer. The elongation and branching phases, managed by glycogen synthase and branching enzymes respectively, ensure a highly branched architecture that allows for the rapid mobilization of glucose units during times of high metabolic demand. Conversely, glycogenolysis describes the distinct breakdown process where glycogen phosphorylase serves as the rate-limiting enzyme, sequentially removing glucose residues until debranching enzymes resolve complex branch points to release glucose-1-phosphate. The regulation of these pathways represents a sophisticated example of metabolic control, involving a delicate balance of hormonal signals like glucagon, epinephrine, and insulin. These hormones trigger intracellular cascades—most notably the cyclic AMP (cAMP) pathway—which utilize reversible phosphorylation to reciprocally activate or inhibit key enzymes, ensuring that glycogen synthesis and degradation do not compete in a futile cycle. The role of calcium ions is also highlighted as a vital signal that synchronizes muscle contraction with immediate energy release by activating phosphorylase kinase. Furthermore, the liver exhibits cAMP-independent pathways for glycogen breakdown triggered by alpha-adrenergic receptors and other hormonal signals. Finally, the chapter examines the clinical consequences of metabolic disruption through an analysis of various glycogen storage diseases. These inherited disorders, such as Von Gierke, Pompe, and McArdle syndromes, result from specific enzyme deficiencies that lead to the abnormal accumulation or failure to mobilize glycogen, resulting in symptoms ranging from severe hypoglycemia and liver damage to debilitating muscle weakness.